Pharmacology, Toxicology and Pharmaceutical Science
Anticoagulant Agent
80%
Antivitamin K
42%
Apixaban
21%
Arachidonic Acid
34%
Artery Thrombosis
18%
Atherosclerosis
30%
Atrial Fibrillation
29%
Bleeding
41%
Carbonate Dehydratase
30%
Carbonate Dehydratase IX
18%
Chronic Myeloid Leukemia
25%
Clinical Study
20%
Dabigatran
58%
Dabigatran Etexilate
43%
Dasatinib
19%
Direct Oral Anticoagulant
41%
Diseases
39%
Drug
45%
Heart Infarction
18%
Heparin
28%
Inflammation
28%
Malignant Neoplasm
33%
Mouse
28%
Nanomaterial
39%
Nanoparticle
24%
Nilotinib
19%
Paroxysmal Nocturnal Hemoglobinuria
22%
Pharmacokinetics
22%
Ponatinib
21%
Prospective Study
22%
Prostacyclin
23%
Protein Tyrosine Kinase Inhibitor
37%
Rat
26%
Rivaroxaban
57%
Silicon Carbide
20%
Sulfonamide
18%
Thrombin
24%
Thromboembolism
30%
Thromboplastin
23%
Thrombosis
18%
Thromboxane
57%
Thromboxane A2
48%
Thromboxane A2 Receptor Blocking Agent
25%
Thromboxane Receptor
45%
Thromboxane Receptor Blocking Agent
40%
Thromboxane Synthase
26%
Thromboxane Synthase Inhibitor
61%
Toxicity
23%
Urea
38%
X-Ray
27%
Medicine and Dentistry
Activated Protein C Resistance
32%
Acute Leukemia
15%
Antibody
39%
Antibody Response
19%
Antigen
28%
Assay
100%
Assessment
41%
Atherogenesis
15%
Atherosclerosis
17%
Betrixaban
16%
Blood
19%
Blood Stasis
26%
Cell Function
15%
Cell Survival
15%
Cells
34%
Coagulation
34%
Combination Therapy
19%
COVID-19
60%
COVID-19 Vaccination
24%
Diagnosis
41%
Endothelial Cell
20%
Heparin
18%
Heparin-Induced Thrombocytopenia
16%
Humoral Immunity
18%
Immunoglobulin G
22%
In Vitro
25%
Infection
38%
Inpatient
26%
Laboratory
47%
Masking
15%
Membrane Microparticle
15%
Neutralizing Antibody
60%
Patient
75%
Plasma
42%
Platelet
23%
Procoagulant
26%
Protein
20%
Rivaroxaban
16%
Severe Acute Respiratory Syndrome Coronavirus 2
68%
Syndrome
17%
Therapeutic Procedure
46%
Thrombin
35%
Thrombocyte Aggregation
19%
Thrombocytopenia
17%
Thromboplastin
17%
Thrombosis
38%
Tyrosine-Kinase Inhibitor
15%
Vaccine
47%
Virus
16%
Woman
30%
Biochemistry, Genetics and Molecular Biology
Antibody
22%
Anticoagulation
19%
Aptitude
10%
Blood Level
28%
Coagulation
61%
Coagulation System
10%
Coronavirinae
10%
D-Dimer
12%
Development
9%
Dose
19%
Hemostasis
40%
IC50
9%
Immune Response
9%
Immunoglobulin M
15%
Impedance
10%
Isoform
10%
Kinetics
14%
Laboratory Test
13%
Light
18%
Molecule
11%
Mouse
10%
Myeloid
9%
Partial Thromboplastin Time
17%
Platelet
17%
Protease
10%
Protein
11%
Prothrombin Time
13%
Rat Model
16%
Receptor Antagonist
10%
Reverse Transcription Polymerase Chain Reaction
13%
Rivaroxaban
19%
Sample
44%
SARS Coronavirus
36%
Structure Activity Relation
9%
Synthase
16%
Synthesis
24%
Taxonomy
22%
Thrombin
50%
Thrombin Time
16%
Thrombocyte Aggregation
31%
Thrombocyte Function
15%
Thromboxane
22%
Thromboxane A2
22%
Thromboxane Receptor
9%
Time
23%
Tissue Factor Pathway Inhibitor
10%
Tyrosine Kinase Inhibitor
15%
Urea
16%
Virus Load
11%
Vitamin K
11%